Deutsche Bank
BNTC icon

Deutsche Bank’s Benitec Biopharma BNTC Stock Holding History

Deutsche Bank’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
20,820
+718
+4% +$8.52K ﹤0.01% 3082
2026
Q1 		$214K Buy
20,102
+7,795
+63% +$90.3K ﹤0.01% 2976
2025
Q4 		$166K Sell
12,307
-4,438
-27% -$61.4K ﹤0.01% 3104
2025
Q3 		$235K Buy
16,745
+5,792
+53% +$73.9K ﹤0.01% 2978
2025
Q2 		$128K Buy
+10,953
New +$153K ﹤0.01% 3165
2020
Q2 		– Sell
-3
Closed – – 4262
2020
Q1 		$0 Sell
3
-11
-79% -$1.29K ﹤0.01% 4364
2019
Q4 		$1K Buy
+14
New +$2.11K ﹤0.01% 4899
2017
Q3 		– Sell
-4
Closed -$1K – 4876
2017
Q2 		$1K Buy
+4
New +$2.53K ﹤0.01% 4853

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Deutsche Bank's BNTC Position: Q2 2026 in Review

Deutsche Bank increased its Benitec Biopharma (BNTC) stake by 3.6% in Q2 2026, buying an estimated $8.52K and bringing the position to 20,820 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #3082.

Deutsche Bank first reported a position in BNTC in Q2 2017 and has held it in 8 quarters since. 86 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Deutsche Bank held 20,820 shares of Benitec Biopharma worth $279K as of Q2 2026.
  • Deutsche Bank bought 718 Benitec Biopharma shares in Q2 2026, an estimated $8.52K.
  • Benitec Biopharma made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3082 holding.
  • Deutsche Bank first reported a position in Benitec Biopharma in Q2 2017 and has held it in 8 quarters since.
  • 86 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.